Solon Eiendom ASA NOK1.00
Solon Eiendom ASA NOK1.00
-1,11 %
35,60 NOK
-0,40
Kurs
35,60
Hög
36,30
Förändring
-1,11 %
Låg
35,50
Uppdaterad
2019-07-22
Öppen
36,00
Factsheet for Solon Eiendom ASA NOK1.00
Company Profile
Description
Solon Eiendom ASA is a Norway-based residential property development group. The principal activities of the company are to develop, market and sell the residential real estate. It focuses on developing residential real estate projects in the greater Oslo region. In addition, the company is involved in biopharmaceutical business where it owns intellectual property rights to its proprietary therapeutic vaccine, Vacc-4x. The company operates through two business divisions namely Residential real estate development and Biopharmaceutical.
Key Stats
Website: http://www.soloneiendom.no
Headquarter country: Norway
Employees: 10
Market Cap (at close 19-07-2019): NOK 3B
Fiscal Year Ends: december
Stats

Stats 2018 2017 2016 2015 2014
Price/Earnings 11,80 63,70
Forward Price/Earnings
Price/Free Cash Flow 19,60
Return on Assets 5,00 -3,40 2,30 -67,90 -35,40
Return on Equity 21,80 -13,30 7,90 -85,40 -40,00
Return on Invested Capital 6,40 -3,80 3,50 -85,90 -40,00
Dividend


Dividend/Share:1,10
Ex. Dividend Date:2018-12-31
Trailing Dividend Yield:5,62
Payout Ratio:164,16
Date Currency Amount
2018-06-30 NOK 1,15
2017-06-30 NOK 1,03
Income Statement

Revenue 2018 2017 2016 2015 2014
Total Revenue 900,11 848,43 691,50 0,09 1,77
Gross Profit 0,25 0,14 0,13 0,00 0,00
Gross Margin % 28,04% 16,92% 19,21% 100,00% 30,80%
Operating Expenses 2018 2017 2016 2015 2014
EBITDA 196,00 104,00 71,00 -85,00 -58,00
Net income 137,00 -67,00 22,00 -97,00 -68,00
Basic Earnings Per Share 2,46 -1,38 0,66 -35,63 -26,50
Operating Income 0,17 0,08 0,10 -0,10 -0,07
Operating Margin % 19,43% 9,27% 13,80% -114 650,59% -3 934,09%
Cash Flow

Cash Flow 2018 2017 2016 2015 2014
Operating Cash Flow -622,00 -402,00 49,00 -82,00 -64,00
Capital Expenditures -4,00 -1,00 -15,00 -2,00
Free Cash Flow -626,00 -404,00 34,00 -84,00 -64,00
Balance Sheet

Assets 2018-12-31 2017-12-31 2016-12-31 2015-12-31 2014-12-31
Current Assets 3 319,94 2 129,32 1 485,94 33,30 116,78 114,96
Long Term Assets 7,63 8,84 347,43 64,12 70,67 81,82
Total Assets 3 327,57 2 138,16 1 833,37 97,42 187,44 196,79
Liabilities 2018-12-31 2017-12-31 2016-12-31 2015-12-31 2014-12-31
Total Current Liabilities 1 183,58 759,81 620,46 31,21 27,00 16,78
Long Term Liabilities 715,86 0,00
Total Liabilities 1 336,32 31,21
Equity 2018-12-31 2017-12-31 2016-12-31 2015-12-31 2014-12-31
Retained Earnings 683,17 456,43 -268,01 -171,23 -103,18
Treasury Stock
Total Stockholder Equity 742,52 509,88 497,05 66,21 160,44 180,00
Net Tangible Assets 742,52 509,88 376,78 9,60 93,06 101,84